Tjerk Bueters

1.6k total citations
40 papers, 1.0k citations indexed

About

Tjerk Bueters is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Tjerk Bueters has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 10 papers in Pharmacology. Recurrent topics in Tjerk Bueters's work include Neuroscience and Neuropharmacology Research (10 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Computational Drug Discovery Methods (8 papers). Tjerk Bueters is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Computational Drug Discovery Methods (8 papers). Tjerk Bueters collaborates with scholars based in Sweden, United Kingdom and United States. Tjerk Bueters's co-authors include Mia von Euler, Olof Bendel, Gabriel von Euler, Johan Sandin, Sandra A. G. Visser, Sven Ove Ögren, Chantal Smulders, Regina G.D.M. van Kleef, Henk P.M. Vijverberg and Bart A. Ploeger and has published in prestigious journals such as Journal of Biological Chemistry, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Tjerk Bueters

39 papers receiving 982 citations

Peers

Tjerk Bueters
Shinghung Mak Hong Kong
Tjerk Bueters
Citations per year, relative to Tjerk Bueters Tjerk Bueters (= 1×) peers Shinghung Mak

Countries citing papers authored by Tjerk Bueters

Since Specialization
Citations

This map shows the geographic impact of Tjerk Bueters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tjerk Bueters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tjerk Bueters more than expected).

Fields of papers citing papers by Tjerk Bueters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tjerk Bueters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tjerk Bueters. The network helps show where Tjerk Bueters may publish in the future.

Co-authorship network of co-authors of Tjerk Bueters

This figure shows the co-authorship network connecting the top 25 collaborators of Tjerk Bueters. A scholar is included among the top collaborators of Tjerk Bueters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tjerk Bueters. Tjerk Bueters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Visser, Sandra A. G. & Tjerk Bueters. (2017). Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts. European Journal of Pharmaceutical Sciences. 109. S72–S77. 5 indexed citations
2.
Eklund, Göran, Jonas Malmquist, Britt‐Marie Swahn, et al.. (2013). Biotransformation of Two β-Secretase Inhibitors Including Ring Opening and Contraction of a Pyrimidine Ring. Drug Metabolism and Disposition. 41(5). 1134–1147. 4 indexed citations
3.
Bueters, Tjerk, et al.. (2013). Rat poorly predicts the combined non-absorbed and presystemically metabolized fractions in the human. Xenobiotica. 43(7). 607–616. 11 indexed citations
4.
Bylund, Johan & Tjerk Bueters. (2013). Presystemic Metabolism of AZ’0908, A Novel mPGES-1 Inhibitor: An In Vitro and In Vivo Cross-Species Comparison. Journal of Pharmaceutical Sciences. 102(3). 1106–1115. 8 indexed citations
5.
Bueters, Tjerk, Bart A. Ploeger, & Sandra A. G. Visser. (2013). The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives. Drug Discovery Today. 18(17-18). 853–862. 33 indexed citations
6.
Sandberg, Lars, Ulrika Yngve, Tjerk Bueters, et al.. (2012). 3-Oxoisoindoline-1-carboxamides: Potent, State-Dependent Blockers of Voltage-Gated Sodium Channel NaV1.7 with Efficacy in Rat Pain Models. Journal of Medicinal Chemistry. 55(15). 6866–6880. 55 indexed citations
7.
Sandberg, Lars, Tjerk Bueters, Anders Eriksson, et al.. (2012). Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers. Bioorganic & Medicinal Chemistry Letters. 22(17). 5618–5624. 12 indexed citations
8.
Bylund, Johan, et al.. (2012). Novel Bioactivation Mechanism of Reactive Metabolite Formation from Phenyl Methyl-Isoxazoles. Drug Metabolism and Disposition. 40(11). 2185–2191. 8 indexed citations
9.
Sandberg, Lars, Alexander B. E. Minidis, Tjerk Bueters, et al.. (2012). Phenethyl nicotinamides, a novel class of NaV1.7 channel blockers: Structure and activity relationship. Bioorganic & Medicinal Chemistry Letters. 22(19). 6108–6115. 8 indexed citations
10.
Bueters, Tjerk, Janet Hoogstraate, & Sandra A. G. Visser. (2008). Correct assessment of new compounds using in vivo screening models can reduce false positives. Drug Discovery Today. 14(1-2). 89–94. 11 indexed citations
11.
Bueters, Tjerk, Mia von Euler, Olof Bendel, & Gabriel von Euler. (2007). Degeneration of newly formed CA1 neurons following global ischemia in the rat. Experimental Neurology. 209(1). 114–124. 46 indexed citations
12.
Moe, Morten C., et al.. (2007). TRANSPLANTATION OF STEM CELLS FROM THE ADULT HUMAN BRAIN TO THE ADULT RAT BRAIN. Neurosurgery. 60(6). 1089–1099. 41 indexed citations
13.
Bueters, Tjerk, et al.. (2007). Combined approach for high‐throughput preparation and analysis of plasma samples from exposure studies. Rapid Communications in Mass Spectrometry. 21(13). 1965–1972. 18 indexed citations
14.
Bendel, Olof, Kanar Alkass, Tjerk Bueters, Mia von Euler, & Gabriel von Euler. (2005). Reproducible loss of CA1 neurons following carotid artery occlusion combined with halothane-induced hypotension. Brain Research. 1033(2). 135–142. 45 indexed citations
15.
Bueters, Tjerk, Marloes J.A. Joosen, Herman P.M. van Helden, Adriaan P. IJzerman, & Meindert Danhof. (2003). Adenosine A1 Receptor Agonist N6-Cyclopentyladenosine Affects the Inactivation of Acetylcholinesterase in Blood and Brain by Sarin. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1307–1313. 22 indexed citations
16.
Smulders, Chantal, Tjerk Bueters, Regina G.D.M. van Kleef, & Henk P.M. Vijverberg. (2003). Selective effects of carbamate pesticides on rat neuronal nicotinic acetylcholine receptors and rat brain acetylcholinesterase. Toxicology and Applied Pharmacology. 193(2). 139–146. 75 indexed citations
17.
Bueters, Tjerk, et al.. (2003). Partial adenosine A1 receptor agonists inhibit sarin-induced epileptiform activity in the hippocampal slice. European Journal of Pharmacology. 471(2). 97–104. 14 indexed citations
18.
Bueters, Tjerk, Leonie M. van Duivenvoorde, Meindert Danhof, Adriaan P. IJzerman, & Herman P.M. van Helden. (2003). Cyclopentyladenosine and some of its low-efficacy derivatives inhibit striatal synaptosomal release of acetylcholine to a similar degree. European Journal of Pharmacology. 481(2-3). 141–146. 1 indexed citations
19.
Joosen, Marloes J.A., Tjerk Bueters, & Herman P.M. van Helden. (2003). Cardiovascular effects of the adenosine A1 receptor agonist N 6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning. Archives of Toxicology. 78(1). 34–39. 18 indexed citations
20.
Bueters, Tjerk, Herman P.M. van Helden, Meindert Danhof, & Adriaan P. IJzerman. (2002). Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release. European Journal of Pharmacology. 454(2-3). 177–182. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026